Skip to content
10-Q

Quarterly Report

PROPANC BIOPHARMA, INC. PPCB

0001493152-26-007052

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Feb 16, 2026 15.86M sh
Shares Diluted Q2 2026 · Dec 31, 2025 13.36M sh
Shares Diluted Q2 2026 · Dec 31, 2025 12.85M sh
Shares Diluted Q2 2026 · Dec 31, 2024 13.35K sh
Shares Diluted Q2 2026 · Dec 31, 2024 11.6K sh
Capex Q2 2026 · Dec 31, 2025 $4.76K
Operating Cash Flow Q2 2026 · Dec 31, 2025 −$2.94M
Operating Cash Flow restated Q2 2026 · Dec 31, 2024 −$216.79K
Long Term Debt Q2 2026 · Dec 31, 2025 $55K
Long Term Debt Q2 2026 · Jun 30, 2025 $537.92K
Stockholders Equity Q2 2026 · Dec 31, 2025 $10.45M
Stockholders Equity Q2 2026 · Sep 30, 2025 $14.36M
Stockholders Equity Q2 2026 · Jun 30, 2025 $13.91M
Stockholders Equity Q2 2026 · Dec 31, 2024 −$4.16M
Stockholders Equity Q2 2026 · Sep 30, 2024 −$4.11M
Stockholders Equity Q2 2026 · Jun 30, 2024 −$3.78M
Current Liabilities Q2 2026 · Dec 31, 2025 $3.62M
Current Liabilities Q2 2026 · Jun 30, 2025 $5.58M
Total Liabilities Q2 2026 · Dec 31, 2025 $3.66M
Total Liabilities Q2 2026 · Jun 30, 2025 $5.73M
Current Assets Q2 2026 · Dec 31, 2025 $7.71M
Current Assets Q2 2026 · Jun 30, 2025 $8.35M
Total Assets Q2 2026 · Dec 31, 2025 $15.11M
Total Assets Q2 2026 · Jun 30, 2025 $19.63M
Eps Diluted Q2 2026 · Dec 31, 2025 −$0.30
Eps Diluted Q2 2026 · Dec 31, 2025 −$0.69
Eps Diluted Q2 2026 · Dec 31, 2024 −$32.23
Eps Diluted restated Q2 2026 · Dec 31, 2024 −$67.65
Eps Basic Q2 2026 · Dec 31, 2025 −$0.30
Eps Basic Q2 2026 · Dec 31, 2025 −$0.69
Eps Basic Q2 2026 · Dec 31, 2024 −$32.23
Eps Basic restated Q2 2026 · Dec 31, 2024 −$67.65
Sga Expense Q2 2026 · Dec 31, 2025 $3.63M
Sga Expense Q2 2026 · Dec 31, 2025 $8.23M
Sga Expense Q2 2026 · Dec 31, 2024 $153.59K
Sga Expense Q2 2026 · Dec 31, 2024 $374.35K
Rd Expense Q2 2026 · Dec 31, 2025 $19.96K
Rd Expense Q2 2026 · Dec 31, 2025 $80.16K
Rd Expense Q2 2026 · Dec 31, 2024 $54.39K
Rd Expense Q2 2026 · Dec 31, 2024 $116.1K
Net Income Q2 2026 · Dec 31, 2025 −$3.09M
Net Income Q2 2026 · Dec 31, 2025 −$7.93M
Net Income Q2 2026 · Sep 30, 2025 −$4.84M
Net Income Q2 2026 · Dec 31, 2024 −$430.18K
Net Income Q2 2026 · Dec 31, 2024 −$784.49K
Net Income Q2 2026 · Sep 30, 2024 −$354.31K
Operating Income Q2 2026 · Dec 31, 2025 −$3.65M
Operating Income Q2 2026 · Dec 31, 2025 −$8.33M
Operating Income Q2 2026 · Dec 31, 2024 −$213.38K
Operating Income Q2 2026 · Dec 31, 2024 −$504.17K